15
04, 2014
14
04, 2014
Valentina Guarneri et al., Double-Blind, Placebo-Controlled, Multicenter, Randomized, Phase IIB Neoadjuvant Study of Letrozole-Lapatinib in Postmenopausal Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative, Operable Breast Cancer. Journal of Clinical Oncology
Diatech Pharmacogenetics2022-04-20T12:48:00+02:00
14
04, 2014
1
04, 2014
18
03, 2014
13
01, 2014
16
09, 2013
5
08, 2013
1
08, 2013
11
07, 2013